Reconsideration of the clinical management of hepatic hemangioma

Table 3 Efficacy of ablation for hepatic hemangioma

Ref.	Years	Type	Treatment	Efficacy
Wen et al[29]	2018	Multicenter retrospective study	RFA	Complete ablation was achieved in 86% of hepatic hemangiomas
Shi et al[30]	2020	Multicenter retrospective study	TAE vs MWA	Microwave ablation was associated with higher rates of radiological complete response (89.0% vs 37.7%) and clinical complete response (88.6% vs 69.2%), fewer minor complications (43.9% vs 66.0%), shorter duration of analgesic drug use and hospital stay
Wu et al[31]	2021	Multicenter retrospective study	RFA	Complete ablation was achieved in 99% of hepatic hemangiomas
Kong et al[32]	2022	Multicenter retrospective study	MWA vs RFA	Microwave ablation was associated with shorter ablation duration, fewer hemolysis-related complications, and shorter hospital stays
Xu et al[33]	2023	Multicenter retrospective study	RFA	Complete ablation was achieved in 95.5% of hepatic hemangiomas. Preoperative symptoms disappeared completely in 96.4% of the patients. During follow-up, 11.4% of patients with hemangioma close to completely disappear over time
Cai et al[35]	2024	Multicenter retrospective study	MWA vs percutaneous sclerotherapy	Microwave ablation has a lower local tumor progression rate, higher volume reduction rate, and symptom remission rate

RFA: Radiofrequency ablation; TAE: Transarterial embolization; MWA: Microwave ablation.